Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Oken

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
Phase II trial of interferon-alpha in locally recurrent or metastatic squamous cell carcinoma of the head and neck: immunological and clinical correlatesD R Vlock, J Andersen, L A Kalish, et al.
Blood|April 18, 1998
Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory GroupP R Greipp, T Leong, J M Bennett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group studyH S Hochster, K M Kim, M D Green, et al.
Blood|April 15, 1992
Varying intensity of postremission therapy in acute myeloid leukemiaP A Cassileth, E Lynch, J D Hines, et al.
Leukemia|June 22, 2001
Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomyR Fonseca, M M Oken, D Harrington, et al.
Blood|February 1, 1989
Small lymphocytic lymphoma: a clinicopathologic analysis of 268 casesJ Ben-Ezra, J S Burke, W G Swartz, et al.
Annals of Internal Medicine|April 15, 1989
Chronic lymphocytic leukemia: recommendationsB D Cheson, J M Bennett, K R Rai, et al.
American Journal of Hematology|November 1, 1988
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working groupB D Cheson, J M Bennett, K R Rai, et al.
Blood|March 7, 1998
BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory studyJ N Winter, J Andersen, J C Reed, et al.
Cancer|October 1, 1983
Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphomaG J Johnson, W G Costello, M M Oken, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|November 1, 1996
Phase II trial of interferon-alpha in locally recurrent or metastatic squamous cell carcinoma of the head and neck: immunological and clinical correlatesD R Vlock, J Andersen, L A Kalish, et al.
Blood|April 18, 1998
Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory GroupP R Greipp, T Leong, J M Bennett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1992
Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group studyH S Hochster, K M Kim, M D Green, et al.
Blood|April 15, 1992
Varying intensity of postremission therapy in acute myeloid leukemiaP A Cassileth, E Lynch, J D Hines, et al.
Leukemia|June 22, 2001
Deletions of chromosome 13 in multiple myeloma identified by interphase FISH usually denote large deletions of the q arm or monosomyR Fonseca, M M Oken, D Harrington, et al.
Blood|February 1, 1989
Small lymphocytic lymphoma: a clinicopathologic analysis of 268 casesJ Ben-Ezra, J S Burke, W G Swartz, et al.
Annals of Internal Medicine|April 15, 1989
Chronic lymphocytic leukemia: recommendationsB D Cheson, J M Bennett, K R Rai, et al.
American Journal of Hematology|November 1, 1988
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working groupB D Cheson, J M Bennett, K R Rai, et al.
Blood|March 7, 1998
BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory studyJ N Winter, J Andersen, J C Reed, et al.
Cancer|October 1, 1983
Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphomaG J Johnson, W G Costello, M M Oken, et al.
Pageof 15